Page 47 - 1.HTAIn_Process_Manual
P. 47
a Costs associated with the
intervention (drugs, vaccine, health
technology)/Program costs:
a.1 Start-up costs/scale up costs (Yes=1, Any capital investment: building,
No=2, NA=3) space, equipment, health worker
trainings
a.2 Implementation/operational costs Service delivery, monitoring and
(Yes=1, No=2, NA=3) supervision, administration, support,
IEC/BCC materials, personnel
b Treatment costs (Yes=1, No=2, Cost of treatment at various levels of
NA=3) service delivery:
primary/secondary/tertiary,
drugs/diagnostic, hospitalisation,
management of complication
1.5.4.2 Patient costs
a Direct costs (Yes=1, No=2, NA=3) Medical (drugs, diagnostics,
procedural, hospital charges) and Non-
medical (transportation, boarding &
lodging)
b Indirect costs (Yes=1, No=2, NA=3) Loss of wages, employment and less
productivity due to morbidity
1.5.5 Health benefits
1.5.5.1 Source: effectiveness estimates for Specify the sources for effectiveness
intervention (Primary=1, estimates. Whether primary data was
Secondary=2, Both=3) collected or estimated from literature
were considered.
1.5.5.2 Immediate/short term outcomes
reported (Yes=1, No=2, NA=3)
1.5.5.3 Long term outcomes reported
(Yes=1, No=2, NA=3)
46 | P a g e
